These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
246 related articles for article (PubMed ID: 27143361)
21. Distinct mechanisms for Ctr1-mediated copper and cisplatin transport. Sinani D; Adle DJ; Kim H; Lee J J Biol Chem; 2007 Sep; 282(37):26775-26785. PubMed ID: 17627943 [TBL] [Abstract][Full Text] [Related]
22. CRISP-R/Cas9 Mediated Deletion of Copper Transport Genes CTR1 and DMT1 in NSCLC Cell Line H1299. Biological and Pharmacological Consequences. Ilyechova EY; Bonaldi E; Orlov IA; Skomorokhova EA; Puchkova LV; Broggini M Cells; 2019 Apr; 8(4):. PubMed ID: 30959888 [TBL] [Abstract][Full Text] [Related]
23. Uptake of the anticancer drug cisplatin mediated by the copper transporter Ctr1 in yeast and mammals. Ishida S; Lee J; Thiele DJ; Herskowitz I Proc Natl Acad Sci U S A; 2002 Oct; 99(22):14298-302. PubMed ID: 12370430 [TBL] [Abstract][Full Text] [Related]
24. Claudin-3 and claudin-4 regulate sensitivity to cisplatin by controlling expression of the copper and cisplatin influx transporter CTR1. Shang X; Lin X; Manorek G; Howell SB Mol Pharmacol; 2013 Jan; 83(1):85-94. PubMed ID: 23053666 [TBL] [Abstract][Full Text] [Related]
25. Characterization of mouse embryonic cells deficient in the ctr1 high affinity copper transporter. Identification of a Ctr1-independent copper transport system. Lee J; Petris MJ; Thiele DJ J Biol Chem; 2002 Oct; 277(43):40253-9. PubMed ID: 12177073 [TBL] [Abstract][Full Text] [Related]
26. Copper transporter 2 regulates the cellular accumulation and cytotoxicity of Cisplatin and Carboplatin. Blair BG; Larson CA; Safaei R; Howell SB Clin Cancer Res; 2009 Jul; 15(13):4312-21. PubMed ID: 19509135 [TBL] [Abstract][Full Text] [Related]
27. Cellular pharmacology of cisplatin in relation to the expression of human copper transporter CTR1 in different pairs of cisplatin-sensitive and -resistant cells. Beretta GL; Gatti L; Tinelli S; Corna E; Colangelo D; Zunino F; Perego P Biochem Pharmacol; 2004 Jul; 68(2):283-91. PubMed ID: 15194000 [TBL] [Abstract][Full Text] [Related]
28. Copper transport activity of yeast Ctr1 is down-regulated via its C terminus in response to excess copper. Wu X; Sinani D; Kim H; Lee J J Biol Chem; 2009 Feb; 284(7):4112-22. PubMed ID: 19088072 [TBL] [Abstract][Full Text] [Related]
29. Relative contribution of CTR1 and DMT1 in copper transport by the blood-CSF barrier: implication in manganese-induced neurotoxicity. Zheng G; Chen J; Zheng W Toxicol Appl Pharmacol; 2012 May; 260(3):285-93. PubMed ID: 22465424 [TBL] [Abstract][Full Text] [Related]
30. Essential role for mammalian copper transporter Ctr1 in copper homeostasis and embryonic development. Lee J; Prohaska JR; Thiele DJ Proc Natl Acad Sci U S A; 2001 Jun; 98(12):6842-7. PubMed ID: 11391005 [TBL] [Abstract][Full Text] [Related]
31. How copper traverses cellular membranes through the mammalian copper transporter 1, Ctr1. Ohrvik H; Thiele DJ Ann N Y Acad Sci; 2014 May; 1314():32-41. PubMed ID: 24697869 [TBL] [Abstract][Full Text] [Related]
32. A Deeper Insight in Metal Binding to the hCtr1 N-terminus Fragment: Affinity, Speciation and Binding Mode of Binuclear Cu Magrì A; Tabbì G; Naletova I; Attanasio F; Arena G; Rizzarelli E Int J Mol Sci; 2022 Mar; 23(6):. PubMed ID: 35328348 [TBL] [Abstract][Full Text] [Related]
34. Cisplatin stabilizes a multimeric complex of the human Ctr1 copper transporter: requirement for the extracellular methionine-rich clusters. Guo Y; Smith K; Petris MJ J Biol Chem; 2004 Nov; 279(45):46393-9. PubMed ID: 15326162 [TBL] [Abstract][Full Text] [Related]
35. Effects of the loss of Atox1 on the cellular pharmacology of cisplatin. Safaei R; Maktabi MH; Blair BG; Larson CA; Howell SB J Inorg Biochem; 2009 Mar; 103(3):333-41. PubMed ID: 19124158 [TBL] [Abstract][Full Text] [Related]
36. Role of the copper transporter, CTR1, in platinum-induced ototoxicity. More SS; Akil O; Ianculescu AG; Geier EG; Lustig LR; Giacomini KM J Neurosci; 2010 Jul; 30(28):9500-9. PubMed ID: 20631178 [TBL] [Abstract][Full Text] [Related]
37. X-ray structures of the high-affinity copper transporter Ctr1. Ren F; Logeman BL; Zhang X; Liu Y; Thiele DJ; Yuan P Nat Commun; 2019 Mar; 10(1):1386. PubMed ID: 30918258 [TBL] [Abstract][Full Text] [Related]
38. Contribution of the major copper influx transporter CTR1 to the cellular accumulation of cisplatin, carboplatin, and oxaliplatin. Holzer AK; Manorek GH; Howell SB Mol Pharmacol; 2006 Oct; 70(4):1390-4. PubMed ID: 16847145 [TBL] [Abstract][Full Text] [Related]
39. Uptake of copper from plasma proteins in cells where expression of CTR1 has been modulated. Kidane TZ; Farhad R; Lee KJ; Santos A; Russo E; Linder MC Biometals; 2012 Aug; 25(4):697-709. PubMed ID: 22354499 [TBL] [Abstract][Full Text] [Related]
40. The mammalian copper transporters CTR1 and CTR2 and their roles in development and disease. Wee NK; Weinstein DC; Fraser ST; Assinder SJ Int J Biochem Cell Biol; 2013 May; 45(5):960-3. PubMed ID: 23391749 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]